Cannabinoids Potential in Treating Colon Cancer | cannabisMD

Cannabinoids Potential in Treating Human Colon Cancer Lines

Cannabinoids Treating Human Colon Cancer Lines

Cannabinoids are a group of chemicals derived from the cannabis plant (cannabis sativa). Cannabidiol (CBD) is one of these chemicals and research has shown that it has anti inflammatory properties to heal animals with nervous system disorders. Tetrahydrocannabinol (THC) is another one of these compounds that wields a psychoactive effect in animals. Cannabinoid receptors (CB1 and CB2) are found in the endogenous cannabinoid system and allow cannabinoids to bind and do their job in the body. This paper will look at how cannabinoids can be induced into human colon cancer cell lines and how they are beneficial to the human condition.

Here is the full scientific article if you wish to download it.

Main Points

  • Cannabinoids may be good for cancer fight
  • Cannabinoids have antiproliferative properties

Cannabinoids may be good for cancer fight

Cannabinoids are a class of chemicals that have the know how to trigger two specific receptor subtypes, the cannabinoid CB1 and CB2 receptors. CB1 receptor is a G-protein-coupled receptor that is linked to the signal transduction pathways. The cumulative impacts of this receptor have detrimental implications in the mediation of cell survival and cell death having the wits to control tumor cell growth. In this connection, intrigue has been set on factors such as sex steroid hormones, which control CB1 receptor expression. CB1 gene expression was found out using quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) in DLD-1, HT-29 and SW620 cells treated at contrasting times and doses of 17b-estradiol exposure. CB1 protein expression was detected by the Western immunoblot method.

Cannabinoids have antiproliferative properties

This current study gives more knowledge on the mechanisms by which estrogens can change colon cancer proliferation. It was demonstrated in the past that the inhibitory impact of estrogens on gastric cell lines. The exposure of a human estrogen receptor-positive gastric cancer cell line to progressive increasing 17b-estradiol concentrations caused a massive anti-proliferative action and an enhanced apoptotic rate, in a dose-dependent way. It was also seen that the estradiol has the ability to relate to molecules like polyamine and growth factors required for cell proliferation. Recently, it was illustrated that an estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells, indicating that the cholesterol metabolism could be considered another target for the estrogenic antiproliferative abilities.

Jonathan Neilly
Jonathan Neilly
Jonathan Neilly is registered with the British Psychological Society, breaking the taboo on mental health issues is one of the driving forces in his life. His background in biomedicine gives him additional understanding of the factors that work together to influence the human condition.

Leave a Reply

Your email address will not be published. Required fields are marked *